STONY BROOK, N.Y., Nov. 29 /PRNewswire-FirstCall/ -- Applied DNA
Sciences, Inc. (OTC Bulletin Board: APDN), a DNA security solutions
company, today announced the launch of its redesigned website at
The redesigned website aims to increase awareness of APDN's
SigNature(TM) Program that enables our customers to mark their products
with unique plant-derived genomes. The SigNature(TM) platform is secure,
accurate and cost-effective. With Signature(TM) DNA Markers, our customers
can quickly and reliably identify original products and eliminate
counterfeits. APDN's SigNature(TM) Markers are readily incorporated in a
broad range of items such as artwork and collectibles, fine wine, consumer
products, digital media, pharmaceuticals, financial instruments and other
The website is also intended to provide potential clients and investors
around the world with instant and easy access to APDN news, opportunities
and industry developments. The new APDN home page displays an overview of
the company and provides links to recent company news items, press releases
and upcoming industry events. Users can also browse the website to find out
other useful information about the company, the SigNature(TM) Program and
information relevant to investors including the ability to register to
receive email updates about the company. An additional feature of this
website is the development of secure extranets which are being designed to
facilitate customer support and communication and to provide up-to-date
information to employees, consultants and clients of APDN.
Dr. James A. Hayward, CEO of APDN, stated, "We are pleased with our
redesigned website, which we believe clearly promotes our new strategic
focus. We expect it to be an informative and effective means to communicate
with our shareholders, potential clients and industry partners worldwide.
The website was designed to deliver the key message that our technology is
accurate, secure and versatile."
About Applied DNA Sciences, Inc.
Applied DNA Sciences, Inc. (APDN) provides botanical DNA encryption,
embedment and authentication solutions that can help protect companies,
governments and consumers from counterfeiting, fraud, piracy, product
diversion, identity theft and unauthorized intrusion into physical
locations and databases. Our common stock is registered under Section 12(g)
of the Securities Exchange Act of 1934 and is listed on the
Over-The-Counter Bulletin Board under the symbol "APDN". Contact: Debbie
Bailey, Applied DNA Sciences, Inc., 25 Health Sciences Drive, Stony Brook,
New York 11790; Tel: 631-444- 8090; Fax: 631-444-8848 http://www.ADNAS.com.
The statements made by Applied DNA Sciences, Inc. may be
forward-looking in nature and are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements describe the Company's future plans,
projections, strategies and expectations, and are based on assumptions and
involve a number of risks and uncertainties, many of which are beyond the
control of Applied DNA Sciences, Inc. Actual results could differ
materially from those projected due to changes in interest rates, market
competition, changes in the local and national economies, and various other
factors detailed from time to time in Applied DNA Sciences' SEC reports and
filings, including our Annual Report on Form 10-KSB, filed on January 12,
2006, our subsequent Quarterly Reports on Form 10-QSB, and our Current
Reports on Form 8-K. The Company undertakes no obligation to update
publicly any forward-looking statements to reflect new information, events
or circumstances after the date hereof to reflect the occurrence of
SOURCE Applied DNA Sciences, Inc.